Q: What is BPC-157?
A: It is a synthetic 15-amino-acid peptide that has been investigated for potential biological effects involving tissue response, gastrointestinal tissues, and recovery-related pathways.
Q: Does it heal injuries?
A: It has shown tissue-repair-related effects in laboratory and animal research, but there is not sufficient human clinical evidence to establish that it heals injuries or accelerates recovery in people.
Q: Why is it associated with gut health?
A: Much of the early research involving BPC-157 examined gastrointestinal tissues and experimental models of gastrointestinal injury. That research has generated interest in the peptide, but it does not establish BPC-157 as a proven treatment for gastrointestinal diseases.
Q: Can it be used for joint or tendon concerns?
A: Preclinical research has explored it in connective tissue and injury models. Human evidence is limited, however, so improvement in joint, tendon, or ligament conditions cannot be predicted or guaranteed.
Q: Is it an anti-inflammatory medication?
A: Research has investigated it’s activity in pathways associated with inflammation, but it is not an FDA-approved anti-inflammatory treatment and should not be represented as a proven therapy for inflammatory conditions.
Q: How long might a BPC-157 protocol last?
A: Treatment duration is individualized. Our healthcare provider will determine the appropriate dosing schedule and reassess whether continued treatment is appropriate based on your response and clinical circumstances.